User menu

A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation.

Bibliographic reference Besancenot, Rodolphe ; Chaligné, Ronan ; Tonetti, Carole ; Pasquier, Florence ; Marty, Caroline ; et. al. A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation.. In: PLoS Biology, Vol. 8, no.9, p. 0 (2010)
Permanent URL http://hdl.handle.net/2078.1/141191
  1. Robb L, Cytokine receptors and hematopoietic differentiation, 10.1038/sj.onc.1210756
  2. Chang Lufen, Karin Michael, Mammalian MAP kinase signalling cascades, 10.1038/35065000
  3. Filippi M.-D., Requirement for mitogen-activated protein kinase activation in the response of embryonic stem cell-derived hematopoietic cells to thrombopoietin in vitro, 10.1182/blood.v99.4.1174
  4. Rouyez M C, Boucheron C, Gisselbrecht S, Dusanter-Fourt I, Porteu F, Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway., 10.1128/mcb.17.9.4991
  5. Lordier L., Jalil A., Aurade F., Larbret F., Larghero J., Debili N., Vainchenker W., Chang Y., Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling, 10.1182/blood-2008-03-144956
  6. N Vitrat, Blood, 91, 3711 (1998)
  7. Nagata Yuka, Muro Yoshinao, Todokoro Kazuo, Thrombopoietin-induced Polyploidization of Bone Marrow Megakaryocytes Is Due to a Unique Regulatory Mechanism in Late Mitosis, 10.1083/jcb.139.2.449
  8. Vigon I., Mornon J. P., Cocault L., Mitjavila M. T., Tambourin P., Gisselbrecht S., Souyri M., Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily., 10.1073/pnas.89.12.5640
  9. Collado Manuel, Blasco Maria A., Serrano Manuel, Cellular Senescence in Cancer and Aging, 10.1016/j.cell.2007.07.003
  10. Ohtani Naoko, Mann David J., Hara Eiji, Cellular senescence: Its role in tumor suppression and aging, 10.1111/j.1349-7006.2009.01123.x
  11. Mooi W.J., Peeper D.S., Oncogene-Induced Cell Senescence — Halting on the Road to Cancer, 10.1056/nejmra062285
  12. Acosta Juan C., O'Loghlen Ana, Banito Ana, Guijarro Maria V., Augert Arnaud, Raguz Selina, Fumagalli Marzia, Da Costa Marco, Brown Celia, Popov Nikolay, Takatsu Yoshihiro, Melamed Jonathan, d'Adda di Fagagna Fabrizio, Bernard David, Hernando Eva, Gil Jesús, Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence, 10.1016/j.cell.2008.03.038
  13. Kuilman Thomas, Michaloglou Chrysiis, Vredeveld Liesbeth C.W., Douma Sirith, van Doorn Remco, Desmet Christophe J., Aarden Lucien A., Mooi Wolter J., Peeper Daniel S., Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network, 10.1016/j.cell.2008.03.039
  14. Wajapeyee Narendra, Serra Ryan W., Zhu Xiaochun, Mahalingam Meera, Green Michael R., Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7, 10.1016/j.cell.2007.12.032
  15. Krizhanovsky Valery, Yon Monica, Dickins Ross A., Hearn Stephen, Simon Janelle, Miething Cornelius, Yee Herman, Zender Lars, Lowe Scott W., Senescence of Activated Stellate Cells Limits Liver Fibrosis, 10.1016/j.cell.2008.06.049
  16. Lin A. W., Barradas M., Stone J. C., van Aelst L., Serrano M., Lowe S. W., Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling, 10.1101/gad.12.19.3008
  17. Michaloglou Chrysiis, Vredeveld Liesbeth C. W., Soengas Maria S., Denoyelle Christophe, Kuilman Thomas, van der Horst Chantal M. A. M., Majoor Donné M., Shay Jerry W., Mooi Wolter J., Peeper Daniel S., BRAFE600-associated senescence-like cell cycle arrest of human naevi, 10.1038/nature03890
  18. Serrano Manuel, Lin Athena W, McCurrach Mila E, Beach David, Lowe Scott W, Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a, 10.1016/s0092-8674(00)81902-9
  19. Gray-Schopfer V C, Cheong S C, Chong H, Chow J, Moss T, Abdel-Malek Z A, Marais R, Wynford-Thomas D, Bennett D C, Cellular senescence in naevi and immortalisation in melanoma: a role for p16?, 10.1038/sj.bjc.6603283
  20. Krimpenfort Paul, IJpenberg Annemieke, Song Ji-Ying, van der Valk Martin, Nawijn Martijn, Zevenhoven John, Berns Anton, p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a, 10.1038/nature06084
  21. J Munro, Cancer Res, 59, 2516 (1999)
  22. Pantoja Cristina, Serrano Manuel, Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras, 10.1038/sj.onc.1202880
  23. Braig Melanie, Lee Soyoung, Loddenkemper Christoph, Rudolph Cornelia, Peters Antoine H.F.M., Schlegelberger Brigitte, Stein Harald, Dörken Bernd, Jenuwein Thomas, Schmitt Clemens A., Oncogene-induced senescence as an initial barrier in lymphoma development, 10.1038/nature03841
  24. Collado Manuel, Gil Jesús, Efeyan Alejo, Guerra Carmen, Schuhmacher Alberto J., Barradas Marta, Benguría Alberto, Zaballos Angel, Flores Juana M., Barbacid Mariano, Beach David, Serrano Manuel, Tumour biology: Senescence in premalignant tumours, 10.1038/436642a
  25. N Komatsu, Blood, 87, 4552 (1996)
  26. Porteu F, Rouyez M C, Cocault L, Bénit L, Charon M, Picard F, Gisselbrecht S, Souyri M, Dusanter-Fourt I, Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin., 10.1128/mcb.16.5.2473
  27. Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y, Kanakura Y, Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5., 10.1128/mcb.17.5.2933
  28. Byun H.-O., Han N.-K., Lee H.-J., Kim K.-B., Ko Y.-G., Yoon G., Lee Y.-S., Hong S.-I., Lee J.-S., Cathepsin D and Eukaryotic Translation Elongation Factor 1 as Promising Markers of Cellular Senescence, 10.1158/0008-5472.can-08-4042
  29. D. X Mason, Oncogene, 23, 9238 (2004)
  30. Kuilman Thomas, Peeper Daniel S., Senescence-messaging secretome: SMS-ing cellular stress, 10.1038/nrc2560
  31. Novakova Z, Hubackova S, Kosar M, Janderova-Rossmeislova L, Dobrovolna J, Vasicova P, Vancurova M, Horejsi Z, Hozak P, Bartek J, Hodny Z, Cytokine expression and signaling in drug-induced cellular senescence, 10.1038/onc.2009.318
  32. Coppé Jean-Philippe, Kauser Katalin, Campisi Judith, Beauséjour Christian M., Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence, 10.1074/jbc.m603307200
  33. Coppé Jean-Philippe, Patil Christopher K, Rodier Francis, Sun Yu, Muñoz Denise P, Goldstein Joshua, Nelson Peter S, Desprez Pierre-Yves, Campisi Judith, Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor, 10.1371/journal.pbio.0060301
  34. Matsumura Itaru, Nakajima Koichi, Wakao Hiroshi, Hattori Seisuke, Hashimoto Koji, Sugahara Hiroyuki, Kato Takashi, Miyazaki Hiroshi, Hirano Toshio, Kanakura Yuzuru, Involvement of Prolonged Ras Activation in Thrombopoietin-Induced Megakaryocytic Differentiation of a Human Factor-Dependent Hematopoietic Cell Line, 10.1128/mcb.18.7.4282
  35. Min Irene M., Pietramaggiori Giorgio, Kim Francis S., Passegué Emmanuelle, Stevenson Kristen E., Wagers Amy J., The Transcription Factor EGR1 Controls Both the Proliferation and Localization of Hematopoietic Stem Cells, 10.1016/j.stem.2008.01.015
  36. Harada Takeshi, Morooka Takaya, Ogawa Satoshi, Nishida Eisuke, 10.1038/35074516
  37. Choi B. H., Kim C. G., Bae Y.-S., Lim Y., Lee Y. H., Shin S. Y., p21Waf1/Cip1 Expression by Curcumin in U-87MG Human Glioma Cells: Role of Early Growth Response-1 Expression, 10.1158/0008-5472.can-07-5222
  38. CHANG Y., BLUTEAU D., DEBILI N., VAINCHENKER W., From hematopoietic stem cells to platelets : Megakaryocytic differentiation, 10.1111/j.1538-7836.2007.02472.x
  39. Motohashi H., Kimura M., Fujita R., Inoue A., Pan X., Takayama M., Katsuoka F., Aburatani H., Bresnick E. H., Yamamoto M., NF-E2 domination over Nrf2 promotes ROS accumulation and megakaryocytic maturation, 10.1182/blood-2009-05-223107
  40. Baccini V., Role of p21Cip1/Waf1 in cell-cycle exit of endomitotic megakaryocytes, 10.1182/blood.v98.12.3274
  41. Gilles L., Guieze R., Bluteau D., Cordette-Lagarde V., Lacout C., Favier R., Larbret F., Debili N., Vainchenker W., Raslova H., P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1, 10.1182/blood-2007-09-113266
  42. Raslova H., Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation, 10.1182/blood-2005-07-3005
  43. Wagner-Ballon O., Pisani D. F., Gastinne T., Tulliez M., Chaligne R., Lacout C., Aurade F., Villeval J.-L., Gonin P., Vainchenker W., Giraudier S., Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice, 10.1182/blood-2006-10-054502